{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,11]],"date-time":"2024-08-11T00:47:35Z","timestamp":1723337255081},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,5,20]],"date-time":"2020-05-20T00:00:00Z","timestamp":1589932800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,5,20]],"date-time":"2020-05-20T00:00:00Z","timestamp":1589932800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Schmerz"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1007\/s00482-020-00479-5","type":"journal-article","created":{"date-parts":[[2020,5,20]],"date-time":"2020-05-20T09:03:49Z","timestamp":1589965429000},"page":"350-353","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Medikamenteninduziertes reversibles zerebrales Vasokonstriktionssyndrom","Drug-induced reversible cerebral vasoconstriction syndrome"],"prefix":"10.1007","volume":"34","author":[{"given":"Moritz Luigi","family":"Schmidbauer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank Arne","family":"Wollenweber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Straube","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katharina","family":"Kamm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,5,20]]},"reference":[{"issue":"9","key":"479_CR1","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1586\/ern.11.112","volume":"11","author":"S-P Chen","year":"2011","unstructured":"Chen\u00a0S\u2011P et al (2011) Reversible cerebral vasoconstriction syndrome: current and future perspectives. Expert Rev Neurother 11(9):1265\u20131276","journal-title":"Expert Rev Neurother"},{"issue":"10","key":"479_CR2","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1016\/S1474-4422(12)70135-7","volume":"11","author":"A Ducros","year":"2012","unstructured":"Ducros\u00a0A (2012) Reversible cerebral vasoconstriction syndrome. Lancet Neurol 11(10):906\u2013917","journal-title":"Lancet Neurol"},{"issue":"4","key":"479_CR3","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1177\/0333102417715223","volume":"38","author":"HA Choi","year":"2018","unstructured":"Choi\u00a0HA et\u00a0al (2018) Characteristics and demographics of reversible cerebral vasoconstriction syndrome: a large prospective series of Korean patients. Cephalalgia 38(4):765\u2013775","journal-title":"Cephalalgia"},{"issue":"12","key":"479_CR4","doi-asserted-by":"publisher","first-page":"3091","DOI":"10.1093\/brain\/awm256","volume":"130","author":"A Ducros","year":"2007","unstructured":"Ducros\u00a0A et\u00a0al (2007) The clinical and radiological spectrum of reversible cerebral vasoconstriction syndrome. A prospective series of 67 patients. Brain 130(12):3091\u20133101","journal-title":"Brain"},{"issue":"1","key":"479_CR5","first-page":"32","volume":"10","author":"J Jensen","year":"2018","unstructured":"Jensen\u00a0J et\u00a0al (2018) The epidemiology of reversible cerebral vasoconstriction syndrome in patients at a\u00a0colorado comprehensive stroke center. J\u00a0Vasc Interv Neurol 10(1):32","journal-title":"J Vasc Interv Neurol"},{"issue":"8","key":"479_CR6","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1001\/archneurol.2011.68","volume":"68","author":"AB Singhal","year":"2011","unstructured":"Singhal\u00a0AB et\u00a0al (2011) Reversible cerebral vasoconstriction syndromes: analysis of 139 cases. Arch Neurol 68(8):1005\u20131012","journal-title":"Arch Neurol"},{"issue":"5","key":"479_CR7","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1002\/ana.21951","volume":"67","author":"SP Chen","year":"2010","unstructured":"Chen\u00a0SP et al (2010) Magnetic resonance angiography in reversible cerebral vasoconstriction syndromes. Annals of neurology 67(5)648\u2013656","journal-title":"Annals of neurology"},{"issue":"2","key":"479_CR8","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1159\/000492462","volume":"12","author":"A Mishra","year":"2018","unstructured":"Mishra\u00a0A, Seril\u00a0D (2018) Posterior reversible encephalopathy syndrome after ustekinumab induction. Am J Gastroenterol 12(2):521\u2013527. https:\/\/doi.org\/10.1159\/000492462","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"479_CR9","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1016\/j.jaad.2018.03.011","volume":"80","author":"B-S Kim","year":"2019","unstructured":"Kim\u00a0B\u2011S et al (2019) Ustekinumab treatment is associated with decreased systemic and vascular inflammation in patients with moderate to severe psoriasis: feasibility study using 18F-fluorodeoxyglucose positron emission tomography-computed tomography. J\u00a0Am Acad Dermatol 80(5):1322\u20131331. https:\/\/doi.org\/10.1016\/j.jaad.2018.03.011","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"479_CR10","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1159\/000492462","volume":"12","author":"A Mishra","year":"2018","unstructured":"Mishra\u00a0A, Seril\u00a0DN (2018) Posterior reversible encephalopathy syndrome following ustekinumab induction for Crohn\u2019s disease. Case Rep Gastroenterol 12(2):521\u2013527","journal-title":"Case Rep Gastroenterol"},{"issue":"2","key":"479_CR11","first-page":"177","volume":"16","author":"L Dickson","year":"2017","unstructured":"Dickson\u00a0L, Menter\u00a0A (2017) Reversible posterior leukoencephalopathy syndrome (RPLS) in a\u00a0psoriasis patient treated with ustekinumab. J\u00a0Drugs Dermatol 16(2):177\u2013179","journal-title":"J. Drugs. Dermatol."},{"issue":"10","key":"479_CR12","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1001\/archdermatol.2011.161","volume":"147","author":"D Gratton","year":"2011","unstructured":"Gratton\u00a0D et\u00a0al (2011) Reversible posterior leukoencephalopathy syndrome in a\u00a0patient treated with ustekinumab: case report and review of the literature. Arch Dermatol 147(10):1197\u20131202","journal-title":"Arch Dermatol"},{"key":"479_CR13","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.jocn.2017.03.042","volume":"42","author":"SP Ban","year":"2017","unstructured":"Ban\u00a0SP et\u00a0al (2017) Reversible cerebral vasoconstriction syndrome combined with posterior reversible encephalopathy syndrome after heart transplantation. J\u00a0Clin Neurosci 42:118\u2013121","journal-title":"J Clin Neurosci"},{"issue":"1","key":"479_CR14","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s12028-016-0320-4","volume":"26","author":"K Feil","year":"2017","unstructured":"Feil\u00a0K et\u00a0al (2017) Reversible cerebral vasoconstriction syndrome and posterior reversible encephalopathy syndrome associated with intracranial hypotension. Neurocrit Care 26(1):103\u2013108","journal-title":"Neurocrit Care"},{"issue":"2","key":"479_CR15","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1111\/head.13466","volume":"59","author":"A Gonzalez-Martinez","year":"2019","unstructured":"Gonzalez-Martinez\u00a0A et al (2019) Tocilizumab-associated reversible cerebral vasoconstriction: a case report. Headache 59(2):259\u2013263","journal-title":"Headache"},{"issue":"5","key":"479_CR16","doi-asserted-by":"publisher","first-page":"e75","DOI":"10.1016\/j.jstrokecerebrovasdis.2017.03.006","volume":"26","author":"S Kodama","year":"2017","unstructured":"Kodama\u00a0S et al (2017) Tacrolimus-induced reversible cerebral vasoconstriction syndrome with delayed multi-segmental vasoconstriction. J\u00a0Stroke Cerebrovasc Dis 26(5):e75\u2013e77","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"1","key":"479_CR17","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1111\/head.12434","volume":"55","author":"H Alibas","year":"2015","unstructured":"Alibas\u00a0H et\u00a0al (2015) Headache during air travel: an unusual cause of reversible cerebral vasoconstriction syndrome. Headache 55(1):174\u2013175","journal-title":"Headache"},{"issue":"8","key":"479_CR18","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1007\/s11739-017-1659-z","volume":"12","author":"S Anticoli","year":"2017","unstructured":"Anticoli\u00a0S, Bravi\u00a0MC, Pezzella\u00a0FR (2017) Reversible cerebral vasoconstriction syndrome after intercontinental airplane travel. Intern Emerg Med 12(8):1327\u20131328","journal-title":"Intern Emerg Med"},{"issue":"11","key":"479_CR19","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1177\/0333102416665226","volume":"37","author":"A Hiraga","year":"2017","unstructured":"Hiraga\u00a0A et\u00a0al (2017) Reversible cerebral vasoconstriction syndrome precipitated by airplane descent: case report. Cephalalgia 37(11):1102\u20131105","journal-title":"Cephalalgia"}],"container-title":["Der Schmerz"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00482-020-00479-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00482-020-00479-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00482-020-00479-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,6]],"date-time":"2024-08-06T02:00:17Z","timestamp":1722909617000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00482-020-00479-5"}},"subtitle":["Ustekinumab als m\u00f6glicher Ausl\u00f6ser?","Ustekinumab as possible trigger?"],"short-title":[],"issued":{"date-parts":[[2020,5,20]]},"references-count":19,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["479"],"URL":"https:\/\/doi.org\/10.1007\/s00482-020-00479-5","relation":{},"ISSN":["0932-433X","1432-2129"],"issn-type":[{"type":"print","value":"0932-433X"},{"type":"electronic","value":"1432-2129"}],"subject":[],"published":{"date-parts":[[2020,5,20]]},"assertion":[{"value":"20 May 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"M.L.\u00a0Schmidbauer, F.A.\u00a0Wollenweber, A.\u00a0Straube und K.\u00a0Kamm geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien. F\u00fcr Bildmaterial oder anderweitige Angaben innerhalb des Manuskripts, \u00fcber die Patienten zu identifizieren sind, liegt von ihnen und\/oder ihren gesetzlichen Vertretern eine schriftliche Einwilligung vor.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}